Henan Newland Pharmaceutical Co. Ltd. A (301277) — Cash Flow Reinvestment Rate
Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting CN¥115.33 Million (capex CN¥101.38 Million plus investments CN¥-13.95 Million) from operating cash flow of CN¥116.94 Million. Check earnings quality score of Henan Newland Pharmaceutical Co. Ltd. A to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Newland Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Henan Newland Pharmaceutical Co. Ltd. A across 6 annual periods. Explore how well can Henan Newland Pharmaceutical Co. Ltd. A service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for Henan Newland Pharmaceutical Co. Ltd. A. For live market cap and broader valuation context, see market cap of Henan Newland Pharmaceutical Co. Ltd. A.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | CN¥115.33 Million | CN¥116.94 Million | CN¥101.38 Million | ▼ -33.9% |
| 2024 | 1.49x | CN¥189.07 Million | CN¥126.76 Million | CN¥110.79 Million | ▲ +71.3% |
| 2023 | 0.87x | CN¥225.97 Million | CN¥259.46 Million | CN¥96.51 Million | ▼ -90.6% |
| 2022 | 9.24x | CN¥765.51 Million | CN¥82.85 Million | CN¥74.34 Million | ▲ +1238.0% |
| 2021 | 0.69x | CN¥33.89 Million | CN¥49.08 Million | CN¥25.40 Million | ▼ -2.2% |
| 2020 | 0.71x | CN¥33.80 Million | CN¥47.86 Million | CN¥16.96 Million | — |